$JAZZ Recent Headlines There’s good news for

New Post Public Reply Private Reply Replies (0) Message Board

Nov 5, 2014 at 12:19 PM

$JAZZ Recent Headlines

There’s good news for speculative growth traders 1:40 p.m. Sept. 2, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 1:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 7:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 9:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 10:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 1:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 11:15 a.m. Sept. 17, 2012 - Val Brickates Kennedy

Jazz Pharmaceuticals (JAZZ) Hits New Lifetime High Today 9:46 a.m. Today - TheStreet.com
Jazz Pharmaceuticals Public (JAZZ) Earnings Report: Q3 2014 Conference Call Transcript 8:50 a.m. Today - TheStreet.com
Jazz Pharmaceuticals Public Limited's (JAZZ) CEO Bruce Cozadd on Q3 2014 Results - Earnings Call Transcript 8:20 p.m. Nov. 4, 2014 - Seeking Alpha
These 5 Drugmakers' Earnings Excelled This Quarter 7:14 p.m. Nov. 4, 2014 - Investors Business Daily
Jazz Beats And Raises Views; Regeneron Misses In Q3 6:02 p.m. Nov. 4, 2014 - Investors Business Daily
Top Funds Buy Ulta Beauty, Alexion, Avago 5:52 p.m. Nov. 4, 2014 - Investors Business Daily
10-Q: JAZZ PHARMACEUTICALS PLC 5:27 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Jazz Pharmaceuticals (JAZZ) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 4, 2014 - Seeking Alpha
Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap 7:02 a.m. Nov. 4, 2014 - Investors Business Daily
Notable earnings after Tuesday's close 5:35 p.m. Nov. 3, 2014 - Seeking Alpha
Video: Alibaba Leads Top Earnings Reports On Tuesday 1:32 p.m. Nov. 3, 2014 - Investors Business Daily
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 3, 2014 - Zacks.com
IBD 50 Caps Impressive 2-Week Rally 5:47 p.m. Oct. 31, 2014 - Investors Business Daily
The Time Is Now For Northwest Biotherapeutics 3:16 p.m. Oct. 29, 2014 - Seeking Alpha
Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings 7:21 a.m. Oct. 29, 2014 - 247WallSt.com
KKR Signals Buying Opportunities 4:03 p.m. Oct. 23, 2014 - The Wall Street Journal Interactive Edition
Cowen’s Sell-Off Shopping List Loaded With Stocks With Huge Upside Potential 8:13 a.m. Oct. 21, 2014 - 247WallSt.com
Insider Trading Alert - AYI, MDSO And JAZZ Traded By Insiders 10:15 a.m. Oct. 17, 2014 - TheStreet.com
Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog 6:04 p.m. Oct. 15, 2014 - Zacks.com
Jazz Pharmaceuticals: An Attractive Play In An Attractive Industry 9:19 a.m. Oct. 13, 2014 - Seeking Alpha

Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Nov. 4, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014 3:05 p.m. Oct. 21, 2014 - PR Newswire - PRF
Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz 8:15 a.m. Oct. 7, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy 8:10 a.m. Sept. 2, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 7:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 8:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 11:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 8:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 8:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 5:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 3:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance 3:05 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 3:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13 3:10 p.m. Aug. 4, 2014 - PR Newswire - PRF
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 8:00 a.m. July 30, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 7:40 a.m. July 29, 2014 - PR Newswire - PRF
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China 10:34 a.m. July 28, 2014 - BusinessWire - BZX
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China 7:03 a.m. July 28, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lear Corporation Talks Future at Morgan Stanley Conference

Why the Chatter at Laguna Conference Matters Alright folks, here's the scoop that the suits over at Lear are gearing up for: a fireside chat at the Morgan Stanley 14th Annual Laguna Conference. At first glance, you might shrug and say, "Big deal." But what's a conference worth if not to attract a bit of investor buzz, right? With Ray Scott, the President and CEO, and...

Eosera Defies Odds with Texas-Made Ear Care Dominance

Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...

ePlus Wins Big: First Ambassador Partner for Everpure

ePlus Breaks Ground with Everpure There's a new chapter unfolding in the tech sector, and ePlus has carved its name on the marquee. Achieving the exclusive Ambassador Partner Status with Everpure, ePlus becomes the first in North America to hit this high note. In the crowded room of tech partnerships, this isn't just a pat on the back—it's a gold star that screams...

Flotek Faces Lawsuit: Investors Urged to Act Fast

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Ecobat's Strategic Shift: Exiting Lithium for Lead

You ever get that sense of déjà vu when another company decides to jump ship from a supposedly hot market? Well, that's where Ecobat's at, folks. This global player in battery recycling just waved goodbye to its lithium recycling biz, closing the deal on its Arizona operations. Previously, they ditched similar holdings in the UK and Germany. Now, they're all-in on their...

AEC Firms Revamp Strategies Amid Talent Tug-of-War

The State of Compensation in AEC Sit back and chew on this—AEC firms are playing a whole new ball game when it comes to compensating their talent. FMI Corporation’s 2026 Compensation Trends Study is putting a spotlight on what really goes on behind the scenes in architecture, engineering, and construction firms. This is about more than just tossing some coin for a...

Scrutinizing GPRO and VCTR Deals for Shareholders

GoPro and Victory Capital: Fair Play or Foul? Ah, mergers and acquisitions—the high-stakes poker game of the corporate world. These days, GoPro (NASDAQ:GPRO) and Victory Capital (NASDAQ:VCTR) find themselves right in the thick of things. Now, I’ve seen enough corporate chess games to know when to raise an eyebrow, and folks, that's exactly what's happening here. The...

Opus Group Revamps Turkish Vehicle Inspection System

Leveraging Expertise in Vehicle Inspection Opus Group is gearing up to revolutionize the vehicle inspection landscape in Türkiye. With a staggering 34.5 million vehicles on the roads, and an annual inspection quota hitting 16 million, the market is ripe for innovation. The U.S.-based Opus Group, a giant in the realm of vehicle inspection programs with about 30 million...

PMI Foods Fuels Hunger Action Month with New Partnership

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Shell Seals ARC Acquisition, $16.5B Bet on Future

Shell’s Strategic Play: Snagging ARC When it comes to Shell, they don't dawdle with peanuts. Snagging ARC Resources Ltd., a Canadian energy firm rooted squarely in British Columbia and Alberta, speaks volumes about their appetite for growth. They’re shelling out approximately US$16.5 billion to pull this deal off the ground. This isn't just some casual sector play; it...